Sign in

    Robert FaveraCapital Management

    Robert Favera is an Equity Analyst at Capital Management, specializing in financial sector research with a particular focus on large-cap U.S. banks and insurance companies such as JPMorgan Chase, Bank of America, and Prudential Financial. He is recognized for maintaining a success rate of approximately 65% with an average annualized return of 8% on his published recommendations, earning positive feedback from industry platforms. Favera began his career as a junior analyst at Franklin Partners in 2012 and advanced through roles at Grantley Advisors before joining Capital Management in 2018. He holds FINRA Series 7 and 63 licenses and is a Chartered Financial Analyst (CFA), reflecting his commitment to analytical rigor and industry best practices.

    Robert Favera's questions to AstroNova Inc (ALOT) leadership

    Robert Favera's questions to AstroNova Inc (ALOT) leadership • Q3 2025

    Question

    Robert Favera from Capital Management asked for a breakdown of MTEX's expenses, inquired if delayed Boeing orders impacted Test & Measurement segment margins, and questioned if product mix drove the sequential decline in Product Identification segment margins.

    Answer

    Executive Thomas DeByle provided a detailed breakdown of MTEX's quarterly expenses from the press release, including selling, R&D, and G&A costs. Executive Gregory Woods confirmed that delayed, high-margin Boeing orders negatively affected T&M margins and that a significant delayed order was the primary factor in the PI segment's margin decline due to product mix.

    Ask Fintool Equity Research AI